We provide you with 20 years of free, institutional-grade data for MGNX stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of MGNX. Explore the full financial landscape of MGNX stock.
Total insider purchase within 3 month on this page: $152,000
Total insider selling within 3 month on this page: -$0
Name | Action | Shares | Avg Price | Amount | Reported Date |
---|---|---|---|---|---|
HEIDEN WILLIAM K | Open Market Purchase | 100,000 | $1.52 | 2025-08-21 | |
Koenig Scott | Derivatives Exercise | 52,829 | 2025-08-15 | ||
Koenig Scott | RSU | 52,829 | 2025-08-15 | ||
Liu Margaret | Derivatives Exercise | 6,500 | 2025-05-22 | ||
Liu Margaret | RSU | 6,500 | 2025-05-22 | ||
Ferrante Karen Jean | Derivatives Exercise | 6,500 | 2025-05-22 | ||
Ferrante Karen Jean | RSU | 6,500 | 2025-05-22 | ||
HURWITZ EDWARD | Derivatives Exercise | 6,500 | 2025-05-22 | ||
HURWITZ EDWARD | RSU | 6,500 | 2025-05-22 | ||
Chhabra Meenu | Derivatives Exercise | 6,500 | 2025-05-22 | ||
Chhabra Meenu | RSU | 6,500 | 2025-05-22 | ||
SIEGEL JAY PHILIP | Derivatives Exercise | 6,500 | 2025-05-22 | ||
SIEGEL JAY PHILIP | RSU | 6,500 | 2025-05-22 | ||
STUMP DAVID C | Derivatives Exercise | 6,500 | 2025-05-22 | ||
STUMP DAVID C | RSU | 6,500 | 2025-05-22 | ||
HEIDEN WILLIAM K | Derivatives Exercise | 6,500 | 2025-05-22 | ||
HEIDEN WILLIAM K | RSU | 6,500 | 2025-05-22 | ||
Jackson Scott Thomas | Derivatives Exercise | 6,500 | 2025-05-22 | ||
Jackson Scott Thomas | RSU | 6,500 | 2025-05-22 | ||
O'Brien Federica F. | Derivatives Exercise | 6,500 | 2025-05-22 | ||
O'Brien Federica F. | RSU | 6,500 | 2025-05-22 | ||
Risser Eric Blasius | Sale | -6,433 | $2.56 | $16,468 | 2025-02-19 |
Risser Eric Blasius | Derivatives Exercise | 16,665 | 2025-02-19 | ||
Risser Eric Blasius | RSU | 16,665 | 2025-02-19 | ||
Smith Beth Ann | Sale | -423 | $2.56 | $1,083 | 2025-02-19 |
Smith Beth Ann | Derivatives Exercise | 1,095 | 2025-02-19 | ||
Smith Beth Ann | RSU | 1,095 | 2025-02-19 | ||
Eck Stephen L. | Sale | -4,942 | $2.56 | $12,652 | 2025-02-19 |
Eck Stephen L. | Derivatives Exercise | 16,665 | 2025-02-19 | ||
Eck Stephen L. | RSU | 16,665 | 2025-02-19 | ||
Spitznagel Thomas | Sale | -5,520 | $2.56 | $14,131 | 2025-02-19 |
Spitznagel Thomas | Derivatives Exercise | 13,332 | 2025-02-19 | ||
Spitznagel Thomas | RSU | 13,332 | 2025-02-19 | ||
Peters Jeffrey Stuart | Sale | -5,147 | $2.56 | $13,176 | 2025-02-19 |
Peters Jeffrey Stuart | Derivatives Exercise | 13,332 | 2025-02-19 | ||
Peters Jeffrey Stuart | RSU | 13,332 | 2025-02-19 | ||
Bonvini Ezio | Derivatives Exercise | 16,665 | 2025-02-19 | ||
Bonvini Ezio | RSU | 16,665 | 2025-02-19 | ||
Koenig Scott | Derivatives Exercise | 42,329 | 2025-02-19 | ||
Koenig Scott | RSU | 42,329 | 2025-02-19 | ||
Karrels James | Sale | -5,790 | $2.56 | $14,822 | 2025-02-19 |
Karrels James | Derivatives Exercise | 14,998 | 2025-02-19 | ||
Karrels James | RSU | 14,998 | 2025-02-19 | ||
Koenig Scott | Grant, award...etc | 31,673 | 2025-02-11 | ||
Koenig Scott | RSU | 31,673 | 2025-02-11 | ||
Smith Beth Ann | Sale | -612 | $2.6 | $1,591 | 2025-02-11 |
Smith Beth Ann | Derivatives Exercise | 1,583 | 2025-02-11 | ||
Smith Beth Ann | RSU | 1,583 | 2025-02-11 | ||
Peters Jeffrey Stuart | Sale | -3,475 | $2.6 | $9,035 | 2025-02-11 |
Peters Jeffrey Stuart | Derivatives Exercise | 9,001 | 2025-02-11 | ||
Peters Jeffrey Stuart | RSU | 9,001 | 2025-02-11 | ||
Spitznagel Thomas | Sale | -3,727 | $2.6 | $9,690 | 2025-02-11 |
Spitznagel Thomas | Derivatives Exercise | 9,001 | 2025-02-11 | ||
Spitznagel Thomas | RSU | 9,001 | 2025-02-11 | ||
Risser Eric Blasius | Sale | -4,311 | $2.6 | $11,209 | 2025-02-11 |
Risser Eric Blasius | Derivatives Exercise | 11,168 | 2025-02-11 | ||
Risser Eric Blasius | RSU | 11,168 | 2025-02-11 | ||
Eck Stephen L. | Sale | -3,312 | $2.6 | $8,611 | 2025-02-11 |
Eck Stephen L. | Derivatives Exercise | 11,168 | 2025-02-11 | ||
Eck Stephen L. | RSU | 11,168 | 2025-02-11 | ||
Bonvini Ezio | Sale | -4,311 | $2.6 | $11,209 | 2025-02-11 |
Bonvini Ezio | Derivatives Exercise | 11,168 | 2025-02-11 | ||
Bonvini Ezio | RSU | 11,168 | 2025-02-11 | ||
Karrels James | Sale | -3,861 | $2.6 | $10,039 | 2025-02-11 |
Karrels James | Derivatives Exercise | 10,002 | 2025-02-11 | ||
Karrels James | RSU | 10,002 | 2025-02-11 | ||
Smith Beth Ann | Initial | 2025-01-13 | |||
HURWITZ EDWARD | Derivatives Exercise | 4,500 | 2024-05-22 | ||
HURWITZ EDWARD | RSU | 4,500 | 2024-05-22 | ||
SIEGEL JAY PHILIP | Derivatives Exercise | 4,500 | 2024-05-22 | ||
SIEGEL JAY PHILIP | RSU | 4,500 | 2024-05-22 | ||
HEIDEN WILLIAM K | Derivatives Exercise | 4,500 | 2024-05-22 | ||
HEIDEN WILLIAM K | RSU | 4,500 | 2024-05-22 | ||
Jackson Scott Thomas | Derivatives Exercise | 4,500 | 2024-05-22 | ||
Jackson Scott Thomas | RSU | 4,500 | 2024-05-22 | ||
STUMP DAVID C | Derivatives Exercise | 4,500 | 2024-05-22 | ||
STUMP DAVID C | RSU | 4,500 | 2024-05-22 | ||
O'Brien Federica F. | Derivatives Exercise | 4,500 | 2024-05-22 | ||
O'Brien Federica F. | RSU | 4,500 | 2024-05-22 | ||
Chhabra Meenu | Derivatives Exercise | 4,500 | 2024-05-22 | ||
Chhabra Meenu | RSU | 4,500 | 2024-05-22 | ||
Liu Margaret | Derivatives Exercise | 4,500 | 2024-05-22 | ||
Liu Margaret | RSU | 4,500 | 2024-05-22 | ||
Ferrante Karen Jean | Derivatives Exercise | 4,500 | 2024-05-22 | ||
Ferrante Karen Jean | RSU | 4,500 | 2024-05-22 | ||
Peters Jeffrey Stuart | Sale | -51,395 | $15.07 | $774,523 | 2024-04-08 |
Peters Jeffrey Stuart | Derivatives Exercise | 42,500 | 2024-04-08 | ||
Peters Jeffrey Stuart | Sale | -19,625 | $21.5 | $421,938 | 2024-03-08 |
Peters Jeffrey Stuart | Derivatives Exercise | 19,625 | 2024-03-08 | ||
Karrels James | Sale | -30,000 | $20.5 | $615,000 | 2024-03-06 |
Spitznagel Thomas | Sale | -10,000 | $20 | $200,000 | 2024-03-06 |
Spitznagel Thomas | Derivatives Exercise | 10,000 | 2024-03-06 | ||
Risser Eric Blasius | Sale | -41,159 | $20 | $823,180 | 2024-03-06 |
Risser Eric Blasius | Derivatives Exercise | 15,000 | 2024-03-06 | ||
Peters Jeffrey Stuart | Sale | -16,124 | $17.22 | $277,655 | 2024-02-28 |
Bonvini Ezio | Sale | -9,366 | $17.11 | $160,252 | 2024-02-26 |
Bonvini Ezio | Derivatives Exercise | 28,125 | 2024-02-26 | ||
Bonvini Ezio | RSU | 28,125 | 2024-02-26 | ||
Peters Jeffrey Stuart | Sale | -10,126 | $17.11 | $173,256 | 2024-02-26 |
Peters Jeffrey Stuart | Derivatives Exercise | 26,250 | 2024-02-26 | ||
Peters Jeffrey Stuart | RSU | 26,250 | 2024-02-26 | ||
Peters Jeffrey Stuart | Sale | -4,441 | $17.4 | $77,273 | 2024-02-20 |
Peters Jeffrey Stuart | Derivatives Exercise | 13,336 | 2024-02-20 | ||
Peters Jeffrey Stuart | RSU | 13,336 | 2024-02-20 | ||
Eck Stephen L. | Sale | -6,872 | $17.4 | $119,573 | 2024-02-20 |
Eck Stephen L. | Derivatives Exercise | 16,670 | 2024-02-20 | ||
Eck Stephen L. | RSU | 16,670 | 2024-02-20 | ||
Cilinski Lynn | Sale | -2,378 | $17.4 | $41,377 | 2024-02-20 |
Cilinski Lynn | Derivatives Exercise | 6,668 | 2024-02-20 | ||
Cilinski Lynn | RSU | 6,668 | 2024-02-20 | ||
Koenig Scott | Sale | -14,349 | $17.4 | $249,673 | 2024-02-20 |
Koenig Scott | Derivatives Exercise | 42,341 | 2024-02-20 | ||
Koenig Scott | RSU | 42,341 | 2024-02-20 | ||
Risser Eric Blasius | Sale | -5,879 | $17.4 | $102,295 | 2024-02-20 |
Risser Eric Blasius | Derivatives Exercise | 16,670 | 2024-02-20 | ||
Risser Eric Blasius | RSU | 16,670 | 2024-02-20 | ||
Spitznagel Thomas | Sale | -5,020 | $17.4 | $87,348 | 2024-02-20 |
Spitznagel Thomas | Derivatives Exercise | 13,336 | 2024-02-20 | ||
Spitznagel Thomas | RSU | 13,336 | 2024-02-20 | ||
Karrels James | Sale | -5,327 | $17.4 | $92,690 | 2024-02-20 |
Karrels James | Derivatives Exercise | 15,003 | 2024-02-20 | ||
Karrels James | RSU | 15,003 | 2024-02-20 | ||
Bonvini Ezio | Sale | -5,871 | $17.4 | $102,155 | 2024-02-20 |
Bonvini Ezio | Derivatives Exercise | 16,670 | 2024-02-20 | ||
Bonvini Ezio | RSU | 16,670 | 2024-02-20 | ||
Bonvini Ezio | Sale | -3,334 | $18 | $60,012 | 2024-02-07 |
Peters Jeffrey Stuart | Sale | -76,251 | $16.5 | $1,258,142 | 2024-02-07 |
Peters Jeffrey Stuart | Derivatives Exercise | 76,251 | 2024-02-07 | ||
Bonvini Ezio | Sale | -13,316 | $15 | $199,740 | 2024-02-02 |
Bonvini Ezio | Sale | -13,316 | $12 | $159,792 | 2024-01-22 |
Bonvini Ezio | Sale | -18,880 | $10.08 | $190,310 | 2023-12-21 |
BIOTECH TARGET N V | Open Market Purchase | 150,000 | $4.46 | 2023-10-04 | |
BIOTECH TARGET N V | Open Market Purchase | 200,000 | $5.26 | 2023-09-11 | |
HURWITZ EDWARD | Open Market Purchase | 15,000 | $4.91 | 2023-09-01 | |
Peters Jeffrey Stuart | Sale | -5,372 | $6.03 | $32,393 | 2023-03-14 |
Peters Jeffrey Stuart | Sale | -3,378 | $6.55 | $22,126 | 2023-02-24 |
Peters Jeffrey Stuart | Derivatives Exercise | 8,750 | 2023-02-24 | ||
Peters Jeffrey Stuart | RSU | 8,750 | 2023-02-24 | ||
Bonvini Ezio | Sale | -3,619 | $6.55 | $23,704 | 2023-02-24 |
Bonvini Ezio | Derivatives Exercise | 9,375 | 2023-02-24 | ||
Bonvini Ezio | RSU | 9,375 | 2023-02-24 |
The information provided in this report about MGNX stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
MacroGenics, Inc(NASDAQ:MGNX)

MacroGenics, Inc., a biopharmaceutical company, discovers and develops antibody-based therapeutics for the treatment of cancer in the United States. The company's approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in com...
Website: http://www.macrogenics.com
Founded: 2000
Full Time Employees: 384
Sector: Healthcare
Industry: Biotechnology